You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Multiple Endocrine Neoplasia Type 2a

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Familial Investigations of Childhood Cancer Predisposition

Recruiting
  • Acute Leukemia
  • +45 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    May 11, 2022

    Advanced Carcinoid Tumor, Digestive System Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston

    Recruiting
    • Advanced Carcinoid Tumor
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 22, 2022

    Medullary Thyroid Carcinoma, Multiple Endocrine Neoplasia Type 2A, Multiple Endocrine Neoplasia Type 2B Trial run by the NCI

    Completed
    Has Results
    • Medullary Thyroid Carcinoma
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 1, 2020

    A Retrospective Study for Multiple Endocrine Neoplasia

    Recruiting
    • Multiple Endocrine Neoplasia
    • no intervention
    • Taipei, Taiwan
      National Taiwan University Hospital
    Apr 2, 2023

    Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

    Recruiting
    • Rare Disorders
    • +309 more
      • Sioux Falls, South Dakota
      • +1 more
      Jun 20, 2022

      Neuroendocrine Tumor of Pancreas, Multiple Endocrine Neoplasia Type 1 Trial in Utrecht (High-dose-high precision MR-guided

      Recruiting
      • Neuroendocrine Tumor of Pancreas
      • Multiple Endocrine Neoplasia Type 1
      • High-dose-high precision MR-guided radiotherapy
      • Utrecht, Netherlands
        UMC Utrecht
      May 29, 2022

      Genetic Factors and Pheochromocytomas in Neoplasia Type 2

      Recruiting
      • Neoplasia
      • Pheochromocytoma
        • Marseille, France
          APHM - Hôpital de la Conception
        Jan 30, 2022

        Natural History Study of Parathyroid Disorders

        Recruiting
        • Parathyroid Cancer
        • +4 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 19, 2023

          Study and Monitoring of Multiple Endocrine Neoplasia Type 1

          Recruiting
          • MEN1
          • Questionnaires
          • Dijon, France
            CHU Dijon Bourgogne
          Jan 4, 2022

          Multiple Endocrine Neoplasia Type 1, Pancreatic Neuroendocrine Tumor Trial in Nanning (EUS-guided fine-needle injection)

          Recruiting
          • Multiple Endocrine Neoplasia Type 1
          • Pancreatic Neuroendocrine Tumor
          • EUS-guided fine-needle injection
          • Nanning, Guangxi, China
            First Affiliated Hospital of Guangxi Medical University
          Sep 24, 2022

          MEN1 Gene Mutation Trial in Basel (Leflunomide 20 mg)

          Not yet recruiting
          • MEN1 Gene Mutation
          • Leflunomide 20 mg
          • Basel, Switzerland
            Unispital Basel
          Nov 1, 2022

          HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

          Recruiting
          • HR+/HER2- Advanced Breast Cancer
          • Targeted Therapy
          • Beijing, Beijing, China
            National Cancer Center/National Clinical Research Center for Can
          Aug 1, 2023

          Routine Transcervical Thymectomy in MEN-1 Patients

          Completed
          • Multiple Endocrine Neoplasia Type 1 (MEN-1)
          • Thymic Carcinoid
          • Routine thymectomy, which has been performed
          • Singapore, Singapore
            National University Hospital
          Sep 25, 2021

          Endocrine Hormones to Hypoglycemia in Type 1 or Type 2 Diabetes

          Completed
          • Diabetes
          • The hyperinsulinaemic hypoglycaemic clamp
          • Nanjing, China
            Nanjing First Hospital, Nanjing Medical Univesity
          Oct 10, 2022

          Vulvar Diseases, HPV Infection, Vulvar HSIL Trial in Cleveland, Mayfield Heights (Artesunate ointment, Placebo ointment)

          Not yet recruiting
          • Vulvar Diseases
          • +12 more
          • Artesunate ointment
          • Placebo ointment
          • Cleveland, Ohio
          • +2 more
          Oct 4, 2023

          Type 2 Diabetes, Multiple Dose Insulin Therapy Trial (Personalized treatment)

          Not yet recruiting
          • Type 2 Diabetes Mellitus
          • Multiple Dose Insulin Therapy
          • Personalized treatment
          • (no location specified)
          Nov 18, 2023

          Multiple Endocrine Neoplasia Type 1, Pancreatic Neuroendocrine Carcinoma Trial in Tampa, Houston (radiation, other, biological)

          Completed
          Has Results
          • Multiple Endocrine Neoplasia Type 1
          • Pancreatic Neuroendocrine Carcinoma
          • Computed Tomography Perfusion Imaging
          • +2 more
          • Tampa, Florida
          • +2 more
          Mar 18, 2020

          Gastrin-Producing Neuroendocrine Tumor, Lung Carcinoid Tumor, Metastatic Digestive System Neuroendocrine Tumor G1 Trial in

          Completed
          Has Results
          • Gastrin-Producing Neuroendocrine Tumor
          • +10 more
          • Laboratory Biomarker Analysis
          • +2 more
          • Boston, Massachusetts
          • +2 more
          Mar 25, 2020

          Obesity; Endocrine; Diabetes Type 2 Trial in Shebin Elkom (Montelukast 10mg, Placebo)

          Active, not recruiting
          • Obesity; Endocrine; Diabetes Type 2
          • Montelukast 10mg
          • Placebo
          • Shebin Elkom, Egypt
            Faculty of Medicine
          Jan 16, 2023

          Obesity, Type 2 Diabetes in Obese Trial in Newark (K-757 and K-833, Matching to K-757 and K-833)

          Active, not recruiting
          • Obesity
          • Type 2 Diabetes Mellitus in Obese
          • K-757 and K-833
          • Matching placebo to K-757 and K-833
          • Newark, Delaware
            QPS, LLC
          Jun 6, 2023

          Healthy, Type 2 Diabetes Trial in United States (LY3938577, Placebo, Insulin degludec)

          Not yet recruiting
          • Healthy
          • Type 2 Diabetes Mellitus
          • Anaheim, California
          • +3 more
          Nov 10, 2023

          Type 2 Diabetes Trial in Beijing (HSK7653 10 mg, HSK7653 25 mg, HSK7653 50 mg)

          Completed
          • Type 2 Diabetes Mellitus
          • HSK7653 10 mg
          • +3 more
          • Beijing, Beijing, China
            Peking university people's hospital
          Sep 23, 2023

          Healthy Subjects, Obesity, T2DM (Type 2 Diabetes) Trial in Changchun (HEC88473 injection, Placebo)

          Completed
          • Healthy Subjects
          • +2 more
          • HEC88473 injection
          • Placebo
          • Changchun, Jilin, China
            The First Hospital of Jilin University
          Jul 14, 2023

          Diabetes, Diabetes, Type 2, Glucose Metabolism Disorders Trial (DWP16001, Dapagliflozin Tablet)

          Not yet recruiting
          • Diabetes Mellitus
          • +4 more
          • (no location specified)
          Aug 16, 2022

          Type 2 Diabetes Trial in Beijing (HS-20094 5mg, HS-20094 10mg, HS-20094 15mg)

          Recruiting
          • Type 2 Diabetes
          • HS-20094 5mg
          • +3 more
          • Beijing, Beijing, China
            Peking University First Hospital
          Nov 3, 2023